Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 +/- Irinotecan and targeted therapy in first-line treatment of metastatic colorectal cancer restricted to the liver
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
Primary objectives: Comparison of radiological and/or clinical progression free survival between the arm with intraarterial oxaliplatin administration (Arms A and C) and those with intravenous oxaliplatin administration (Arms B and D). Progression was assessed according to the criteria RECIST v1.1 and according to the investigator. Primary endpoints: Progression free survival (median)
创建时间：
2020-10-15
